The first example of a patient with etoricoxib-induced immune hemolytic anemia
Transfusion, 08/10/2012
Mayer B et al. – Etoricoxib should be considered as a risk in the development of immune hemolytic anemia, with the causative antibodies potentially reacting with other COX inhibitors.



